Novo gets option to cardiovascular company Staten

Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) gained an option to acquire Staten Biotechnology B.V. (Nijmegen, the Netherlands),

Read the full 173 word article

User Sign In